DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-11.77%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.46B
AUM Growth
+$2.46B
(-10%)
Cap. Flow
+$106M
Cap. Flow
% of AUM
4.31%
Top 10 Holdings %
Top 10 Hldgs %
37.24%
Holding
120
New
16
Increased
26
Reduced
21
Closed
20
Top Buys
| 1 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
$126M |
| 2 |
Vericel Corp
VCEL
|
$36.7M |
| 3 |
Viatris
VTRS
|
$27.2M |
| 4 |
AGN
Allergan plc
AGN
|
$24.1M |
| 5 |
Aclaris Therapeutics
ACRS
|
$20.7M |
Top Sells
| 1 |
DBVT
DBV Technologies
DBVT
|
$65.1M |
| 2 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$62.4M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$26.9M |
| 4 |
Regenxbio
RGNX
|
$20.8M |
| 5 |
Acadia Healthcare
ACHC
|
$20.7M |
Sector Composition
| 1 | Healthcare | 70.85% |
| 2 | Financials | 1.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $133M | 5.34% | 6,825,719 +215,825 | +3% | +$4.22M |
|
|
ORTX
2
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $126M | 5.05% | +8,023,600 | New | +$126M |
|
3
Q32 Bio
QTTB
$20.9M
| $117M | 4.68% | 5,227,035 | – | – |
|
|
4
Viatris
VTRS
$12.3B
| $77.6M | 3.11% | 2,833,741 +991,630 | +54% | +$27.2M |
|
|
5
Vericel Corp
VCEL
$1.83B
| $64.8M | 2.6% | 3,725,900 +2,108,170 | +130% | +$36.7M |
|
|
XLRN
6
DELISTED
Acceleron Pharma Inc.
XLRN
| $60.4M | 2.42% | 1,386,541 +268,890 | +24% | +$11.7M |
|
|
XENT
7
DELISTED
Intersect ENT, Inc
XENT
| $58.6M | 2.34% | 2,078,375 -69,575 | -3% | -$1.96M |
|
8
BioCryst Pharmaceuticals
BCRX
$1.74B
| $55.8M | 2.23% | 6,910,789 | – | – |
|
|
AERI
9
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $54.8M | 2.19% | 1,518,596 -21,852 | -1% | -$789K |
|
|
MYOK
10
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $48.7M | 1.95% | 997,000 +80,000 | +9% | +$3.91M |
|
11
AnaptysBio
ANAB
$569M
| $47.4M | 1.9% | 743,439 +95,973 | +15% | +$6.12M |
|
12
argenx
ARGX
$43.6B
| $45.3M | 1.82% | 472,000 -184,500 | -28% | -$17.7M |
|
|
13
Aclaris Therapeutics
ACRS
$209M
| $43.6M | 1.74% | 5,893,416 +2,800,000 | +91% | +$20.7M |
|
14
Xeris Biopharma Holdings
XERS
$1.26B
| $42.5M | 1.7% | 2,498,666 | – | – |
|
15
eHealth
EHTH
$118M
| $41.4M | 1.66% | 1,076,402 -150,659 | -12% | -$5.79M |
|
16
Universal Health Services
UHS
$11.6B
| $38.7M | 1.55% | 332,000 +70,000 | +27% | +$8.16M |
|
17
Sarepta Therapeutics
SRPT
$1.78B
| $37.3M | 1.49% | 341,800 +45,800 | +15% | +$5M |
|
|
MRTX
18
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $37.1M | 1.48% | 874,486 +33,575 | +4% | +$1.42M |
|
|
NVRO
19
DELISTED
NEVRO CORP.
NVRO
| $35.6M | 1.42% | 914,273 +389,233 | +74% | +$15.1M |
|
20
Centene
CNC
$14.3B
| $33M | 1.32% | 286,000 +41,000 | +17% | +$4.73M |
|
|
PTLA
21
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $32.7M | 1.31% | 1,677,414 -778,172 | -32% | -$15.2M |
|
22
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $31.7M | 1.27% | 1,128,822 +66,866 | +6% | +$1.88M |
|
23
Ascendis Pharma
ASND
$11.8B
| $31.6M | 1.27% | 505,098 +185,098 | +58% | +$11.6M |
|
|
DPLO
24
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $31.6M | 1.27% | 2,348,993 +1,495,306 | +175% | +$20.1M |
|
25
Brookdale Senior Living
BKD
$1.83B
| $28.4M | 1.14% | 4,240,855 -467,057 | -10% | -$3.13M |
|